Author

D. Focosi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

A. Casadevall· 2 shared D. J. Sullivan· 1 shared J. Senefeld· 1 shared M. C. Johnson· 1 shared M. Franchini· 1 shared M. Joyner· 1 shared R. Quiroga· 1 shared S. McConnell· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Casadevall

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintDec 5, 2022

Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves.

D. Focosi, R. Quiroga, S. McConnell…·A. Casadevall

This paper identifies convergent evolution in SARS-CoV-2 Spike protein mutations across variants, leading to increased viral fitness and immune escape, and suggests rethinking antibody therapies.

DOI 10.1101/2022.12.05.518843

virushost-pathogen & immune response

𝕏 PostBluesky

MicrobiologybioRxivNov 25, 2022

Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ1.1 and XBB.1

D. J. Sullivan, M. Franchini, J. Senefeld…·D. Focosi

The paper shows that plasma from individuals who received booster vaccinations or recent Omicron infections neutralizes BQ.1.1 and XBB.1 variants more effectively than naive vaccinated individuals.

DOI 10.1099/jgv.0.001854

humanproteomics

𝕏 PostBluesky